다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

NUVL

Nuvalent (NUVL)

Nuvalent Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NUVL

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	05:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NUVL	Nuvalent Inc
2024/05/17	05:01	PR Newswire (US)	Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655	NASDAQ:NUVL	Nuvalent Inc
2024/05/16	05:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/05/09	19:46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NUVL	Nuvalent Inc
2024/05/09	19:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NUVL	Nuvalent Inc
2024/05/09	19:30	PR Newswire (US)	Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results	NASDAQ:NUVL	Nuvalent Inc
2024/05/09	05:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/04/09	05:30	PR Newswire (US)	Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024	NASDAQ:NUVL	Nuvalent Inc
2024/03/06	06:52	PR Newswire (US)	Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024	NASDAQ:NUVL	Nuvalent Inc
2024/02/27	21:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NUVL	Nuvalent Inc
2024/02/27	20:42	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NUVL	Nuvalent Inc
2024/02/27	20:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NUVL	Nuvalent Inc
2024/02/27	20:30	PR Newswire (US)	Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:NUVL	Nuvalent Inc
2024/02/27	20:15	PR Newswire (US)	Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520	NASDAQ:NUVL	Nuvalent Inc
2024/02/12	20:30	PR Newswire (US)	Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors	NASDAQ:NUVL	Nuvalent Inc
2024/02/01	20:30	PR Newswire (US)	Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:NUVL	Nuvalent Inc
2024/01/10	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/01/10	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/01/10	06:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/01/10	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/01/10	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2024/01/10	06:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NUVL	Nuvalent Inc
2024/01/08	20:30	PR Newswire (US)	Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones	NASDAQ:NUVL	Nuvalent Inc
2023/12/29	07:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2023/12/27	06:31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NUVL	Nuvalent Inc
2023/12/21	20:30	PR Newswire (US)	Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:NUVL	Nuvalent Inc
2023/12/21	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2023/12/21	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc
2023/12/21	06:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NUVL	Nuvalent Inc

검색 관련기사 보기:NASDAQ:NUVL

1 2 3 4 5 6 7 다음 >>

Lucero Energy (QB)

Meritz Inverse 2x Us Tre...

The Castle (CE)

Vontobel Financial Produ...

Tarsus Pharmaceuticals

FTP American Recovery Po...

Defiance Quantum ETF

Region Hauts de France 0...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관